ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,000 shares of the business's stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $18.27, for a total value of $36,540.00. Following the completion of the transaction, the chief executive officer directly owned 130,000 shares of the company's stock, valued at $2,375,100. The trade was a 1.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
ReposiTrak Trading Down 2.4%
TRAK traded down $0.39 on Friday, reaching $16.09. The stock had a trading volume of 90,815 shares, compared to its average volume of 47,728. The company has a 50-day moving average price of $19.78. The company has a market cap of $294.13 million, a P/E ratio of 47.32 and a beta of 0.51. ReposiTrak Inc. has a 12-month low of $15.12 and a 12-month high of $25.01. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01.
ReposiTrak Cuts Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Investors of record on Monday, June 30th will be issued a $0.0182 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a yield of 0.5%. ReposiTrak's dividend payout ratio is presently 20.59%.
Hedge Funds Weigh In On ReposiTrak
Large investors have recently bought and sold shares of the business. Ingalls & Snyder LLC grew its position in shares of ReposiTrak by 1.3% in the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock valued at $3,905,000 after purchasing an additional 2,554 shares during the period. R Squared Ltd purchased a new position in ReposiTrak in the 2nd quarter valued at about $235,000. Finally, Ellsworth Advisors LLC boosted its holdings in ReposiTrak by 10.6% in the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock worth $634,000 after buying an additional 2,997 shares during the last quarter. Institutional investors and hedge funds own 27.35% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Get Our Latest Report on ReposiTrak
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Recommended Stories

Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.